Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Advances in™ Oncology Nursing: Recognizing and Treating Oncologic Emergencies in Patients With Cancer

Release Date: June 30, 2020
Expiration Date: June 30, 2021

Activity Overview

This online educational activity is designed to provide expert insight on the treatment of 3 common oncologic emergencies, with an emphasis on the role of the oncology nurse and nurse practitioners. The essential skills of symptom detection and astute clinical suspicion along with early recognition and prompt management will be highlighted in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward nurses and other healthcare professionals who treat patients with cancer.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Evaluate the risk for patients with cancer to develop various oncologic emergencies, such as tumor lysis syndrome, febrile neutropenia, or hypercalcemia, based on their tumor type, treatment regimen, and other patient factors.
  • Incorporate current and emerging strategies for the treatment and prevention of oncologic emergencies into a plan of care for your patients.
  • Assess key clinical trial data related to the management of oncologic emergencies through emerging treatment strategies.
  • Identify nursing interventions for patients at risk of oncologic emergencies, including use of appropriate monitoring strategies, guideline-based treatment, and supportive care approaches.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Cleveland Clinic Taussig Cancer Institute
Department of Hematologic Oncology and Blood Disorders
Cleveland, OH

Disclosures: Consultant: GlaxoSmithKline, Celgene, Karyopharm.

Laura J. Zitella, MS, RN, ACNP-BC, AOCN
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
Nurse Practitioner
Associate Clinical Professor
University of California San Francisco
San Francisco, CA

Disclosures: Laura J. Zitella, MS, RN, ACNP-BC, AOCN has no relevant financial relationships with commercial interests.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By